Fundraising Fox

Alexander Sinclair-Wilson

Investor

Principal at Qiming Venture Partners

London

Writes $100K – $5M checks · typically $1.5M

About

Dr. Alexander Sinclair-Wilson is a Europe-based Principal who leverages his doctoral scientific expertise to evaluate and back therapeutics-focused, science-driven founders, acting as a bridge to China/US networks for UK/European biotech.

Invests in

AI & Machine LearningBiotechConsumerHealthtechSemiconductors

Experience

  1. Qiming Venture PartnersPrincipalcurrent2024 — presentLondon, United Kingdom
  2. Sanofi VenturesInvestment Team2023 — 2024Greater London, England, United Kingdom
  3. SV Health InvestorsInvestment Team2020 — 2023London, England, United Kingdom
  4. Ecole normale supérieurePostdoctoral Research Fellow2016 — 2019Paris
  5. UCLDoctoral & Postdoctoral Researcher2010 — 2016Wolfson Institute for Biomedical Research
  6. Yale UniversityDoctoral Researcher2013New Haven, Ct.

Colleagues at Qiming Venture Partners

Network2

Investors connected to Alexander in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alexander Sinclair-Wilson?
Dr. Alexander Sinclair-Wilson is a Europe-based Principal who leverages his doctoral scientific expertise to evaluate and back therapeutics-focused, science-driven founders, acting as a bridge to China/US networks for UK/European biotech.
Where does Alexander Sinclair-Wilson work?
Alexander Sinclair-Wilson is Principal at Qiming Venture Partners.
What does Alexander Sinclair-Wilson invest in?
Alexander Sinclair-Wilson invests in AI & Machine Learning, Biotech, Consumer, Healthtech, Semiconductors.
What check size does Alexander Sinclair-Wilson write?
Alexander Sinclair-Wilson typically writes checks of $100K – $5M.
Where did Alexander Sinclair-Wilson go to school?
Alexander Sinclair-Wilson studied at University of Cambridge (BA & MSci, Natural Sciences - Biochemistry); UCL (PhD (Wellcome Trust Scholar), Molecular neurodevelopment); Yale University (Visiting Doctoral Student (Bogue Fellow), Molecular neurodevelopment).

Same school

Shared employers